: Russia’s Sputnik V COVID-19 vaccine shows 91.6% efficacy in late-stage trial
Preliminary findings, published in The Lancet on Tuesday, are based on data gathered from 19,866 participants.
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.